未诊断的G6PD缺乏症在黑人及亚洲人群中普遍存在,并加剧2型糖尿病诊断与并发症的健康不平等
本研究利用UK Biobank和Genes & Health队列的全外显子组测序及电子健康记录数据,评估未诊断的G6PD缺乏症对英国2型糖尿病诊断与并发症的影响。发现黑人及亚洲男性G6PD缺乏症携带率远高于白人,但临床识别率极低;G6PD缺乏者平均HbA1c显著偏低而平均血糖差异 negligible,且微血管并发症风险增高、诊断年龄延迟。结论提示未诊断的G6PD缺乏症对基于HbA1c的糖尿病诊疗有重大影响,可能加剧健康不平等。
要点
- 黑人男性约1/7、亚洲男性约1/63携带G6PD缺乏等位基因,白人男性低于1/10000。
- G6PD缺乏男性平均HbA1c低0.9%(10.0 mmol/mol),平均血糖差异可忽略。
- G6PD缺乏男性微血管并发症风险增高(OR 1.37),诊断年龄平均延迟4.1年。
核心结论
- 未诊断的G6PD缺乏症显著影响基于HbA1c的2型糖尿病诊断,并与糖尿病并发症风险增加相关。
- 该问题对全球使用HbA1c进行诊断和监测的人群有重大影响,可能显著加剧糖尿病结局的不平等。
研究设计与样本
- 研究采用英国生物银行(UK Biobank,n=467,368)和Genes & Health(n=43,011)队列的全外显子组测序与电子健康记录数据。
- 研究评估了未诊断的G6PD缺乏症对英国2型糖尿病诊断及并发症的人群层面影响。
主要发现
- 英国黑人男性约1/7、亚洲男性约1/63携带G6PD缺乏等位基因,白人男性低于1/10000。
- G6PD缺乏男性临床识别率低于1/50。
- 男性G6PD携带者平均HbA1c较非携带者低0.9%(IFCC:10.0 mmol/mol),平均血糖差异可忽略。
- G6PD缺乏男性发生糖尿病相关微血管并发症的比值比为1.37(95% CI:1.01, 1.86)。
- 2011年后诊断2型糖尿病的男性G6PD携带者平均诊断年龄较非携带者大4.1岁(95% CI:0.6, 7.7)。
临床怎么用
- 在黑人及亚洲男性等高风险人群中,应警惕未诊断的G6PD缺乏症对HbA1c解读的干扰。
- 对G6PD缺乏者,不能仅依赖HbA1c评估血糖控制或糖尿病风险,需结合血糖等其他指标。
- 临床应提高G6PD缺乏症的识别率,以避免诊断延迟和并发症风险低估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Glucose-6-phosphate dehydrogenase (G6PD) deficiency presents silently and is not routinely screened. It is associated with markedly lower HbA1c for the prevailing glucose levels. Since HbA1c is internationally recommended to diagnose and manage type 2 diabetes (T2D), we investigated the population-level impact of undiagnosed G6PD deficiency on T2D diagnosis and complications in the U.K. RESEARCH DESIGN AND METHODS: We used whole-exome sequencing and electronic health record data from UK Biobank (n = 467,368) and Genes & Health (n = 43,011) cohorts. RESULTS: In the U.K., we estimated that ∼1 in 7 Black and 1 in 63 Asian males carry G6PD deficiency alleles, compared with fewer than 1 in 10,000 White males. Despite this, less than 1 in 50 G6PD-deficient men are clinically recognized. Male G6PD carriers have considerably lower average HbA1c (0.9% [International Federation of Clinical Chemistry and Laboratory Medicine: 10.0 mmol/mol]) compared with noncarriers, while differences in average glucose were negligible. G6PD-deficient men had 1.37 (95% CI: 1.01, 1.86) higher odds of developing diabetes-related microvascular complications than noncarriers. Although risk factors were similar prior to diagnosis, male G6PD carriers diagnosed with T2D since 2011 were, on average, 4.1 years (95% CI: 0.6, 7.7) older at diagnosis compared with noncarriers. In addition, lower mean HbA1c values in G6PD carriers falsely underestimated their 10-year T2D risk. CONCLUSIONS: Undiagnosed G6PD deficiency has significant impact on T2D diagnosis with HbA1c and associates with increased risk of diabetes complications. This has major implications for global populations using HbA1c for diagnosis and monitoring, and could contribute significantly to inequalities in diabetes outcomes.
引用
- Martin S, Samuel M, Stow D, et al. Undiagnosed G6PD Deficiency in Black and Asian Individuals Is Prevalent and Contributes to Health Inequalities in Type 2 Diabetes Diagnosis and Complications. Diabetes Care. 2025. PMID: 41022122. doi:10.2337/dc25-0556
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。